The importance of these findings was further highlighted by the observation that in addition to the rectal cancer, colon cancer patients from an independent cohort (COADREAD) could be categorized into two groups based on PPME1 mRNA expression, which correspond to differential OS outcome in both univariate and multivariate survival analyses. This evidence concerns the gene PPME1 and malignant colon neoplasm.